AKTX
Akari Therapeutics
AKTX
AKTX
14 hedge funds and large institutions have $1.99M invested in Akari Therapeutics in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 0 closing their positions.
Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Millennium Management
New York
|
$25K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$2K |
Top Sellers
1 |
1
Renaissance Technologies
New York
|
$107K |
2 |
2
Citadel Advisors
Miami,
Florida
|
$62K |
3 |
3
HighTower Advisors
Chicago,
Illinois
|
$33K |
4 |
HF
4
HRT Financial
New York
|
$31K |
5 |
5
Morgan Stanley
New York
|
$9K |